Author Correction: LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade.
Saved in:
| Title: | Author Correction: LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. |
|---|---|
| Authors: | Liu Y; Division of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Debo B; Division of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, UK., Li M; Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, 06510, USA., Shi Z; Division of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Sheng W; Division of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. wanqiang_sheng@zju.edu.cn.; Institute of Immunology, and Department of Respiratory Disease of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China. wanqiang_sheng@zju.edu.cn., Shi Y; Division of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. yang.shi@ludwig.ox.ac.uk.; Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, UK. yang.shi@ludwig.ox.ac.uk. |
| Source: | Nature communications [Nat Commun] 2022 Jan 05; Vol. 13 (1), pp. 263. Date of Electronic Publication: 2022 Jan 05. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
